(New York, NY – February 7, 2020) - Mount Sinai St. Luke's hospital will now operate under the name Mount Sinai Morningside, reinforcing the hospital's integral role as part of the world-renowned Mount Sinai Health System and the primary provider of health care to the 148,000 residents of West Harlem, including Morningside Heights.

The new name was approved by Mount Sinai Health System's Boards of Trustees, the New York State Department of Health, and the New York Secretary of State. The change becomes effective immediately.

"This new name not only reaffirms our 124-year legacy of serving the communities constituting West Harlem, including Morningside Heights, but also our commitment to delivering technologically advanced Mount Sinai-level care to our patients, who are increasingly coming to us from all five boroughs, Westchester, New Jersey, and even internationally," said Arthur A. Gianelli, President of Mount Sinai Morningside and Chief Transformation Officer for the Mount Sinai Health System. "We have undergone a transformation that positions Mount Sinai Morningside as an integral part of the Mount Sinai Health System. Our patients now have convenient access to a vast network of world-renowned physicians and cutting-edge medical care."

"Mount Sinai Morningside has grown into a top-tier health care facility that serves as this region's gateway to the Mount Sinai Health System, expanding access for Upper Manhattan, New Jersey, Yonkers, Westchester, and surrounding areas," said Kenneth L. Davis, MD, President and CEO of the Mount Sinai Health System. "The hospital's rebranding and transformation efforts reaffirm our commitment to setting standards for excellence and innovation in health care through technically advanced and groundbreaking procedures, equipment, and research that result in better outcomes for our patients."

Mount Sinai Morningside's transformation is the result of hundreds of millions of dollars in investments in clinical services, facilities, equipment, and information technology. Physicians with international reputations have been recruited, and a number of international clinical trials have been launched at Mount Sinai Morningside. Centers of excellence have been established in cardiology and cardiac surgery; diabetes, endocrinology and bariatric surgery; geriatrics; and trauma services. Numerous investments have been made to upgrade Mount Sinai Morningside, including the installation of new clinical equipment, the introduction of a state-of-the-art electronic medical record (EMR) system, acquisition of best-in-class surgical robotic technology, and the construction of a soon-to-open inpatient unit with all private rooms.

Association Viewpoints Homepage